Vitamin Angels to expand MMS access in Cambodia amid high maternal anemia prevalence

Pregnant women with supplements
Approximately 51% of pregnant women in Cambodia experience anemia. (Getty Images)

Vitamin Angels looks to support the scale-up of multiple micronutrient supplements (MMS) for pregnant women in Cambodia amid high prevalence of maternal anemia.

This is a partnership with Cambodia’s Ministry of Health (MOH), with the two entities working together to strengthen the national antenatal care platform through policy development, healthcare worker training, and product access.

As part of the collaboration, Vitamin Angels has committed more than 100,000 bottles of MMS that are expected to reach nearly one-third of Cambodia’s pregnant women in 2027.

This comes timely as approximately 51% of pregnant women in Cambodia experience anemia, which increases the risk of severe bleeding during childbirth and is associated with adverse birth outcomes.

Furthermore, approximately 37,300 babies are born with low birth weight—representing more than one in 10 newborns— each year in Cambodia.

These figures underscore the urgent need to improve maternal nutrition to help protect the health of women and give children a healthier start in life.

Vitamin Angels has been supporting the introduction and scale-up of MMS in Cambodia since 2021, including providing technical support for the country’s first MMS adherence and acceptability study.

Explore related questions

Since 2024, this effort has advanced through Transforming Lives Through Nutrition, a consortium comprising other nonprofit organizations, including Helen Keller Intl and iDE.

“Addressing maternal and child malnutrition at the magnitude the challenge demands requires combining the strongest evidence available with partnerships, systems, capabilities, financing, policy, and excellence to enable effective implementation, leading to lasting change,” said Dr Ana Céspedes, President and CEO of Vitamin Angels.

“We are honored to partner with Cambodia’s government to offer the technical support and high-impact, cost-effective, evidence-based nutrition solutions that will result in sustainable impact for women and children.”

In 2027, Cambodia aims to introduce MMS to pregnant women across 16 of its 24 provinces, with plans to accelerate the national scale-up in years to come.

Multi-stakeholder effort

Currently, work is in progress to add MMS to Cambodia’s National Essential Medicines List (EML).

Additionally, Vitamin Angels will partner with the MOH’s Department of Drugs and Food to train stockkeepers and pharmacists on MMS supply chain management.

“The introduction of multiple micronutrient supplementation is an important step in strengthening maternal nutrition and improving health outcomes for women and newborns in Cambodia,” said Dr Phim Laon, manager of National Maternal and Child Health Center (NMCHC)’s National Nutrition Program (NNP), MOH.

“Successful implementation of MMS takes more than making nutrition products available. It requires coordinated planning, clear national guidance, trained health workers, reliable supply, and ongoing learning to improve effective delivery of maternal health interventions.”

The main goal of the NNP is reduce maternal, infant and child mortality by improving the nutritional status of women and children.

A tested and proven formula

Developed in 1999 through collaboration between WHO, United Nations University, and UNICEF, United Nations International Multiple Micronutrient Antenatal Preparation Multiple Micronutrient Supplements (UNIMMAP MMS) contains 15 essential vitamins and minerals, including iron and folic acid.

It is formulated to help meet increased nutritional needs of prenatal women, and has been rigorously tested in randomized controlled trials for safety and effectiveness.

In 2021, it was added to the WHO Model List of Essential Medicines, recognizing it as one of the most proven, cost-effective, and safe interventions for pregnancy.

Studies have shown that compared with iron and folic acid supplementation alone, MMS can reduce infant mortality by up to 29% and reduce the risk of adverse birth outcomes, including low birth weight (up to 19% in anemic or underweight pregnant women), preterm birth (up to 8%), and babies born small for gestational age (up to 9%).

The MMS formulation provided by Vitamin Angels is said to be consistent with the UNIMMAP MMS formula and manufactured to international quality standards.